What Is the Success Rate of PRK Surgery? | Lasik Awards

Quick Answer

PRK surgery achieves 20/20 or better uncorrected vision in approximately 90–95% of appropriately selected patients in published clinical studies. Approximately 98–99% achieve 20/40 or better — the legal driving standard in most U.S. states. Patient satisfaction rates exceed 95% at 12 months in large series. Outcomes are comparable to LASIK at the 1-year mark and beyond, with PRK offering structural advantages for certain patient profiles.

Detailed Explanation

“Success rate” in refractive surgery is a term that deserves precise definition. The figures cited in advertising, clinical studies, and patient forums can mean different things depending on what outcome is being measured.

How Success Is Defined Clinically

20/20 or better: The patient can read the 20/20 line on a distance acuity chart without glasses or contacts. This is the gold standard outcome and the benchmark most patients care about.

20/40 or better: The legal driving standard in most states. Nearly all PRK patients in well-selected populations achieve this. If 20/40 is the threshold, success rates approach 98–99%.

Uncorrected visual acuity (UCVA) vs. best-corrected visual acuity (BCVA): UCVA measures what you can see without any correction. BCVA measures what you can see with the best possible glasses prescription. A complication that reduces BCVA (best possible corrected vision) is more serious than one that leaves some residual refractive error correctable with mild glasses.

Surgeon-measured vs. patient-reported: Objective visual acuity measurements are one dimension. Patient satisfaction surveys — capturing quality of vision, halos, night vision, and daily function — are another. Strong PRK programs report high marks on both.

Published Clinical Outcomes

The following data reflects pooled findings from peer-reviewed studies of PRK in appropriately selected patients:

| Outcome Measure | Approximate Rate | |—|—| | UCVA 20/20 or better at 12 months | 90–95% | | UCVA 20/40 or better at 12 months | 98–99% | | Patient satisfaction at 12 months | 95–97% | | Enhancement/retreatment rate | 5–10% | | Serious complication rate (vision loss > 2 lines BCVA) | < 1% | | Clinically significant haze (with MMC use) | < 1% |

A 2020 meta-analysis in *JAMA Ophthalmology* reviewing outcomes across multiple refractive procedures found no statistically significant difference in long-term visual acuity outcomes between PRK and LASIK in matched patient populations.

Factors That Improve PRK Outcomes

Prescription magnitude: Lower prescriptions achieve higher rates of 20/20 outcomes. Patients with mild myopia (-1.00 to -4.00 D) consistently achieve 20/20 at rates exceeding 95%. Higher myopia (-6.00 to -10.00 D) has more variability — the tissue removal required is greater, healing response is less predictable, and regression rates are higher.

Surgeon experience and case volume: High-volume refractive surgeons who perform 300–1,000+ PRK procedures annually have refined nomograms — the specific laser settings applied to each prescription — that improve accuracy. Experienced surgeons also identify subtle pre-operative findings that disqualify borderline candidates before surgery, improving their population-level outcomes.

Pre-operative screening quality: The outcome rate quoted above reflects properly screened patients — those who passed comprehensive corneal evaluation before surgery. Including poorly screened patients would reduce any practice’s success rate. Rigorous candidate selection is itself a determinant of success.

Patient compliance: PRK patients who follow the post-operative drop schedule (steroid drops, antibiotic drops, lubricating drops), wear UV protection, and attend all follow-up visits have measurably better outcomes than non-compliant patients.

Technology platform: Current-generation laser platforms (Alcon WaveLight EX500, VISX STAR S4 IR) with iris registration and active eye-tracking produce more consistent ablations than older generation systems. Wavefront-guided treatment, while not universally necessary, may produce superior outcomes for patients with complex prescriptions.

Risks That Can Reduce Outcomes

Regression: Partial return toward the original prescription occurs in a subset of patients, more commonly with higher myopia. Most regression is mild and can be addressed with glasses, contacts, or an enhancement.

Undercorrection/overcorrection: Biological variability in healing response means some eyes overcorrect (become mildly hyperopic) or undercorrect (remain mildly myopic). The enhancement rate of 5–10% reflects this.

Corneal haze: With standard MMC application, clinically significant haze is rare. Without MMC — in clinics that do not routinely apply it — haze rates are higher, and haze can reduce best-corrected vision as well as uncorrected vision.

Ectasia: The most serious long-term risk, affecting a very small percentage of patients (estimated under 0.05% in properly screened populations). Ectasia can progressively reduce vision and may require corneal transplantation in severe cases.

For recognition of surgeons who achieve excellence in PRK outcomes, visit PRK Surgery Awards.

Important Considerations

Success rate is population data — not a personal guarantee. When you read that 92% of PRK patients achieve 20/20, that applies to the average patient in a well-screened population. Your individual outcome depends on your prescription, corneal profile, healing biology, and the quality of your surgeon and center.

Ask your surgeon about their own outcomes data — not the industry average. A surgeon who tracks their outcomes can tell you what percentage of their patients, specifically, achieve 20/20. This is more relevant than national pooled data.

Enhancement is part of the success framework, not a failure. If your outcome at 6 months is 20/40 and you choose enhancement to achieve 20/20, the final result is excellent. Enhancement rates around 5–10% are normal and do not indicate substandard surgery.

10-year data remains strong. PRK was FDA-approved in 1995. Patients treated in the mid-1990s who have been followed for 20+ years show durable outcomes without significant regression in most cases. The long-term data is reassuring.

What to Do Next

1. Ask your surgeon for their personal outcomes data. A surgeon performing 500+ PRK cases annually should be able to tell you their 20/20 rate and enhancement rate.

2. Understand your specific prescription’s outcome profile. Outcomes vary by diopter range. Your surgeon should be able to give you a realistic expectation based on your specific prescription.

3. Review the enhancement policy. Knowing what is covered if the first result requires refinement changes the risk calculation. Can You Get PRK Twice covers enhancement eligibility.

4. Find a qualified surgeon. Outcomes are surgeon-dependent. How Do I Find the Best PRK Surgeon provides the evaluation framework.